Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft Patency”

502 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 502 results

Not applicableLooking for participantsNCT04745221
What this trial is testing

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Who this might be right for
Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Study completedNCT00485225
What this trial is testing

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

Who this might be right for
Chronic, Non Malignant Pain
Durect 77
Not applicableStudy completedNCT01106391
What this trial is testing

A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)

Who this might be right for
Abdominal Aortic Aneurysms
Cordis US Corp. 60
Testing effectiveness (Phase 2)Study completedNCT00186628
What this trial is testing

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Who this might be right for
Leukemia, Mast-CellMantle-cell Lymphoma
Stanford University 36
Testing effectiveness (Phase 2)UnknownNCT02464436
What this trial is testing

Safety and Tolerability of hRPC in Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
ReNeuron Limited 29
Not applicableUnknownNCT04583436
What this trial is testing

Efficacy and Safety Comparison of the Open and Endovascular Surgical Methods for the Treatment of Long Atherosclerotic Lesions of the Femoral-popliteal Segment Below the Knee, TASC D in Patients With Critical Limb Ischemia

Who this might be right for
Atherosclerotic Ischemic DiseaseCritical Limb IschemiaSuperficial Femoral Artery Occlusion+1 more
Meshalkin Research Institute of Pathology of Circulation 90
Post-approval studies (Phase 4)Study completedNCT00289835
What this trial is testing

Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial

Who this might be right for
Coronary Artery Bypass Grafting
Laval University 57
Testing effectiveness (Phase 2)Study completedNCT02743897
What this trial is testing

Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

Who this might be right for
End Stage Renal Disease
University of Pennsylvania 62
Large-scale testing (Phase 3)Study completedNCT01856413
What this trial is testing

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Who this might be right for
Hepatitis B
Biotest 49
Testing effectiveness (Phase 2)Ended earlyNCT01875874
What this trial is testing

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Who this might be right for
Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-Function+1 more
Vital Therapies, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT01063907
What this trial is testing

KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kyowa Kirin Co., Ltd. 95
Large-scale testing (Phase 3)Looking for participantsNCT06235892
What this trial is testing

Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure

Who this might be right for
Organ Grafts
Nantes University Hospital 332
Large-scale testing (Phase 3)Study completedNCT01528709
What this trial is testing

Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)

Who this might be right for
Saphenous Vein Graft Disease
Boca Raton Regional Hospital 173
Large-scale testing (Phase 3)Ended earlyNCT01532453
What this trial is testing

Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients

Who this might be right for
Actinic KeratosesSquamous Cell Carcinomas
Spirig Pharma Ltd. 244
Large-scale testing (Phase 3)UnknownNCT01205802
What this trial is testing

Usability of Ringed Polytetrafluoroethylene Graft for Venous Vascular Reconstruction of Living Donor Liver Transplantation

Who this might be right for
Patency, Hepatic Venous Congestion
Asan Medical Center 200
Post-approval studies (Phase 4)Study completedNCT02342145
What this trial is testing

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

Who this might be right for
Beta-Thalassemia MajorGraft-versus-host Disease (GVHD)
Zhongming Zhang 205
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Not applicableUnknownNCT03880188
What this trial is testing

Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds

Who this might be right for
Wounds and InjuriesWound InfectionFacial Bones Fracture+16 more
Dufresne, Craig, MD, PC 20
Not applicableLooking for participantsNCT06895070
What this trial is testing

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

Who this might be right for
Heart TransplantHeart FailureTransplant; Failure, Heart
XVIVO Perfusion 60
Post-approval studies (Phase 4)Study completedNCT00195429
What this trial is testing

A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 47
Load More Results